Cancer cell plasticity due to the dynamic architecture of protein-protein interactions networks (i.e. interactomes) provides a vexing outlet for therapy evasion. Joshi et al show how forcing interactomes into a state where no rebound pathways can be deployed renders therapeutics with traditionally poor performance to become highly efficacious.
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
×
Cookie Control
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us
and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.
Nature Portfolio Cancer Community is for all those interested in cancer research, including our journal readers and authors, educators, and those working in medicine, industry and healthcare